Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated ...
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, ...
Develops Enhanced CrossLinking and Immunoprecipitation (eCLIP), followed by high-throughput sequencing (eCLIP-seq), to identify RNA transcripts bound in vivo by a protein of interest.
enGene Inc. has developed a highly flexible nucleotide (DNA and RNAi) delivery technology that targets mucosal tissues and can be used to treat numerous prevalent, chronic diseases via the ...
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technologies. Their integrated platform enables the discovery, design and development of ...
Gene therapy requires delivery. Ligandal has developed a breakthrough nanotechnology for the precise and high-efficiency delivery of nucleic acids (CRISPR, TALEN, and RNA) to specific cells and ...
Promosome was founded in 2003 to commercialize discoveries at The Scripps Research Institute by the late Nobel Laureate Dr. Gerald Edelman and his colleague Dr. Vincent Mauro, now Chief Scientific ...
RTLGenomics is a full service sequencing company offering sequencing approaches including barcoding, metagenomics and transcriptomics. A sister lab, MicroGen, is a CAP accredited clinical ...
